02/22 StreetInsider.com Pre-Open Movers:

Axcan Pharma Inc. (Nasdaq: AXCA) 26% LOWER; Said Itopride Did Not Meet Trial Primary Endpoint
This article: 273 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE